SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-18-007654
Filing Date
2018-11-06
Accepted
2018-11-06 17:14:44
Documents
60
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_110618.htm 6-K 9508
2 EXHIBIT 99.1 exh_991p.htm EX-99.1 324139
3 EXHIBIT 99.2 exh_992.htm EX-99.2 197624
4 EXHIBIT 99.3 exh_993.htm EX-99.3 18304
  Complete submission text file 0001171843-18-007654.txt   3220401

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE apto-20180930.xml EX-101.INS 566420
6 XBRL SCHEMA FILE apto-20180930.xsd EX-101.SCH 55074
7 XBRL CALCULATION FILE apto-20180930_cal.xml EX-101.CAL 31395
8 XBRL DEFINITION FILE apto-20180930_def.xml EX-101.DEF 271980
9 XBRL LABEL FILE apto-20180930_lab.xml EX-101.LAB 238429
10 XBRL PRESENTATION FILE apto-20180930_pre.xml EX-101.PRE 287785
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 181163932
SIC: 2836 Biological Products, (No Diagnostic Substances)